Literature DB >> 9555941

Hemin binding and oxidation of lipoproteins in serum: mechanisms and effect on the interaction of LDL with human macrophages.

G Camejo1, C Halberg, A Manschik-Lundin, E Hurt-Camejo, B Rosengren, H Olsson, G I Hansson, G B Forsberg, B Ylhen.   

Abstract

Most models of lipoprotein oxidation by free radicals have excluded macromolecular plasma components from the system. This limits their biological significance because oxidation of lipoproteins appears to occur in the intima in the presence of a plasma ultrafiltrate. Hemin, a product of in vivo hemoglobin degradation, binds and oxidizes purified lipoproteins. However, it is not known whether this occurs in the presence of plasma components that may sequester hemin. We found that hemin in serum diluted to protein levels of the extracellular fluid (10-30%) binds to low and high density lipoproteins (LDL, HDL) with association constants in the nmol/L range. In the presence of H2O2, hemin oxidizes both lipoproteins in diluted serum with formation of conjugated dienes, thiobarbituric acid reacting substances, and F2-isoprostanes. This appeared to be caused by the high affinity of hemin with LDL and by the Fe3+ liberated that remains associated with the particles after hemin is degraded. Spectrophotometric and fluorescence experiments and electrophoresis of porphyrins complex with LDL indicated that the heme ring is buried in the lipoprotein surface-monolayer with the carboxylic groups in contact with positive regions of the protein and the solvent. Human macrophages associated and degraded 3- to 4-times more hemin-oxidized LDL in diluted serum than native LDL. It is possible then that at sites of LDL, accumulation in the extracellular intima, hemin and H2O2 production could cause oxidation with potential atherogenic consequences for cellular lipoprotein processing. This may occur even when other macromolecules of the extracellular fluid are present.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9555941

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

1.  GAPDH regulates cellular heme insertion into inducible nitric oxide synthase.

Authors:  Ritu Chakravarti; Kulwant S Aulak; Paul L Fox; Dennis J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Redox-reactive autoantibodies: biochemistry, characterization, and specificities.

Authors:  John A McIntyre; W Page Faulk
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

3.  Macrophages, extracellular matrix, and lipoproteins in arterial cholesterol balance.

Authors:  Germán Camejo; Eva Hurt-Camejo
Journal:  J Lipid Res       Date:  2013-11-19       Impact factor: 5.922

4.  Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH.

Authors:  Xiurong Zhao; Jaroslaw Aronowski
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

5.  Iron and noncontrast magnetic resonance T2* as a marker of intraplaque iron in human atherosclerosis.

Authors:  Marshall W Winner; Travis Sharkey-Toppen; Xiaolan Zhang; Michael L Pennell; Orlando P Simonetti; Jay L Zweier; Patrick S Vaccaro; Subha V Raman
Journal:  J Vasc Surg       Date:  2014-03-24       Impact factor: 4.268

6.  Identification of amino acid residues involved in heme binding and hemoprotein utilization in the Porphyromonas gingivalis heme receptor HmuR.

Authors:  Xinyan Liu; Teresa Olczak; Hwai-Chen Guo; Dabney W Dixon; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Binding specificity of the Porphyromonas gingivalis heme and hemoglobin receptor HmuR, gingipain K, and gingipain R1 for heme, porphyrins, and metalloporphyrins.

Authors:  T Olczak; D W Dixon; C A Genco
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

8.  In vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques.

Authors:  Subha V Raman; Marshall W Winner; Tam Tran; Murugesan Velayutham; Orlando P Simonetti; Peter B Baker; John Olesik; Beth McCarthy; Amy K Ferketich; Jay L Zweier
Journal:  JACC Cardiovasc Imaging       Date:  2008-01

9.  Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes.

Authors:  Magnus Centlow; Piero Carninci; Krisztian Nemeth; Eva Mezey; Michael Brownstein; Stefan R Hansson
Journal:  Fertil Steril       Date:  2007-12-31       Impact factor: 7.329

10.  Depletion of haptoglobin and hemopexin promote hemoglobin-mediated lipoprotein oxidation in sickle cell disease.

Authors:  Ayla Yalamanoglu; Jeremy W Deuel; Ryan C Hunt; Jin Hyen Baek; Kathryn Hassell; Katie Redinius; David C Irwin; Dominik J Schaer; Paul W Buehler
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-07-26       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.